WHO ICTRP trial
Randomized, two treatment, two sequence, two period, two way crossover
CTRI/2024/04/065321 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/04/065321 |
|---|---|
| Public title | Randomized, two treatment, two sequence, two period, two way crossover |
| Scientific title | An open-label, balanced, randomized, two treatment, two sequence, two period, two way crossover, single oral dose bioequivalence study of fixed-dose combination of Bisoprolol Fumarate 5 mg Tablets + Perindopril arginine 10 mg Tablets of Servier India Private Limited and Reference product : EU… |
| Primary sponsor | Servier India Private Limited |
| Secondary sponsors | Servier India Private Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | BA/BE |
| Countries | India |
| Interventions | Intervention1: Reference product (B): Concor (Bisoprolol Fumarate) 5 mg film-coated tablets of Merck Kft., Hungary and Coversyl (Perindopril arginine) 10 mg film-coated tablets of Les Laboratoires Servier 50 rue Carnot 92284 Suresnes cedex… |
| Registration date | May 4, 2024 |
| Target size | 58 |
| Secondary IDs | CT-07-22/2024;PR/BE/23/124, Version no 02 dated 01/03/2024 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: